<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00324246</url>
  </required_header>
  <id_info>
    <org_study_id>F-7-28-1 CTIL</org_study_id>
    <secondary_id>CMC 06014008</secondary_id>
    <nct_id>NCT00324246</nct_id>
  </id_info>
  <brief_title>Feasibility Study of the NEW NORMA-SENSE</brief_title>
  <official_title>Feasibility Study of the NEW NORMA-SENSE Indicator Strip and Vaginal Secretion Buffer Capacity Measurement - IN-VITRO Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Carmel Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lin Medical Center, Haifa</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Common Sense</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Carmel Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  In-vitro study&#xD;
&#xD;
        -  Collect data regarding the color appearance on the new developed indicator strips (NEW&#xD;
           NORMA-SENSE), in contact with vaginal secretion with elevated pH&#xD;
&#xD;
        -  Measure the buffering capacity of vaginal secretion from non-symptomatic and symptomatic&#xD;
           subjects&#xD;
&#xD;
        -  Detect these indicator strips' performance, in contact with urine&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This in-vitro study was designed to collect data regarding the color appearance on the new&#xD;
      developed indicator strips (NEW NORMA-SENSE) when coming in contact, in-vitro, with vaginal&#xD;
      secretion with elevated pH, and to measure the buffering capacity of vaginal secretion from&#xD;
      non-symptomatic subjects and symptomatic subjects, and to detect these indicator strips'&#xD;
      performance when come in contact with urine.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2006</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">160</enrollment>
  <condition>Vaginal Infection</condition>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      Vaginal secretions.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Women, age between 18 years and 45 years with or without symptoms of vaginal infection.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Women, aged between 18 and 45, with or without symptoms of vaginal infection.&#xD;
&#xD;
          2. Subjects are ready to sign the informed consent form.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Subjects are unable or unwilling to cooperate with the study procedures.&#xD;
&#xD;
          2. Subjects are currently participating in another clinical study that may directly or&#xD;
             indirectly affect the results of this study.&#xD;
&#xD;
          3. Subjects that suffer from vaginal bleeding or menstruate.&#xD;
&#xD;
          4. Subjects that have had sexual relations within the last 12 hours.&#xD;
&#xD;
          5. Subjects that applied local antiseptic, antibiotic or vaginal treatment within the&#xD;
             last 3 days.&#xD;
&#xD;
          6. Subjects that applied vaginal douching within 12 hours prior to the visit at the&#xD;
             clinic.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adam Geva, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Women Health Care Center - Lin Medical Center, Haifa, Israel</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Women Health Care Center - Lin Medical Center</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>January 2007</verification_date>
  <study_first_submitted>May 9, 2006</study_first_submitted>
  <study_first_submitted_qc>May 9, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 10, 2006</study_first_posted>
  <last_update_submitted>June 19, 2008</last_update_submitted>
  <last_update_submitted_qc>June 19, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 20, 2008</last_update_posted>
  <responsible_party>
    <name_title>hadar kessary</name_title>
    <organization>common sense</organization>
  </responsible_party>
  <keyword>vaginal infection</keyword>
  <keyword>color appearance</keyword>
  <keyword>new developed indicator strips (NEW NORMA-SENSE)</keyword>
  <keyword>in-vitro</keyword>
  <keyword>vaginal secretion</keyword>
  <keyword>elevated pH</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

